Allison Institute convenes leading scientists and clinicians for fourth annual scientific symposium on frontiers of immunotherapy
The James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center hosted its fourth annual scientific symposium, “Immune Set Points: Stress, Wellness and System Control,...
UT MD Anderson’s Albert Koong and Katy Rezvani elected to the National Academy of Medicine
Albert Koong, M.D, Ph.D., honored for advances in radiation therapy technologies and new discoveries in cancer biology
Katy Rezvani...
New funded projects from Joint Center for Computational Oncology integrate predictive digital twins to improve patient outcomes
The University of Texas MD Anderson Cancer Center, the Oden Institute for Computational Engineering and Sciences and the Texas Advanced Computing...
New statewide plan aims to eliminate cervical cancer in Texas by 2032
On behalf of a statewide coalition...
UT MD Anderson and Nature to co-host conference on next-generation cancer therapeutics
UT MD Anderson honors visionary leadership of Dr. Peter Pisters following retirement announcement; shares transition plans
The University of Texas MD Anderson Cancer Center today is recognizing the exceptional leadership of Peter WT Pisters, M.D., president, following...
UT MD Anderson ranks No. 1 in the nation for cancer care for 12th year in a row
UT MD Anderson joins global consortium committed to eliminating cervical cancer
The University of Texas MD Anderson Cancer Center today announced it has joined a global consortium dedicated to accelerating the elimination...
ASCO: UT MD Anderson faculty honored as 2026 Special Award recipients
UT MD Anderson names Albert Koong, M.D., Ph.D., chief scientific officer
The University of Texas MD Anderson Cancer Center today announced that Albert Koong, M.D., Ph.D., an internationally recognized physician-scientist...